Corgi Data & Surveillance ETF

EYESNASDAQ · USD
28.96USD0.00 (-0.64%)

Corgi Data & Surveillance ETF (EYES) Wheel Strategy

EYES wheel strategy scan found 7 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 34.8%.

Read more

Running a EYES wheel strategy lets you generate consistent premium income on Corgi Data & Surveillance ETF while setting your own entry and exit prices on the underlying. Corgi Data & Surveillance ETF's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own EYES, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best EYES wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on EYES, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable EYES wheel from a losing one.

On August 30, 2022, Second Sight Medical Products, Inc. underwent a reverse merger, resulting in its acquisition by Nano Precision Medical, Inc. Previously, Second Sight specialized in the creation, production, and commercialization of implantable visual prosthetics, with the goal of restoring artificial vision to individuals who are blind. The company's overarching objective was to advance technologies designed to aid the sight-impaired community. A notable offering was the Orion Visual Cortical Prosthesis System, an implanted cortical stimulator developed to deliver functional artificial vision.

This system targeted individuals suffering from blindness caused by a range of conditions, such as glaucoma, diabetic retinopathy, damage or disease affecting the optic nerve, and other forms of eye injury. Established in 1998, the company was based in Sylmar, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the EYES wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your EYES wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Nov 20, 202629.00$0.45$1.55-0.4456—50.7%34.8%0
Dec 18, 202629.00$0.70$2.00-0.4384—50.2%30.0%1
Nov 20, 202628.00$0.05$1.15-0.3556—61.0%26.8%0
Dec 18, 202628.00$0.35$1.58-0.3684—58.7%24.4%1
Mar 19, 202728.00$0.85$2.63-0.36175—55.3%19.6%0
Mar 19, 202727.00$0.50$2.25-0.32175—61.2%17.4%0
Mar 19, 202726.00$0.10$1.90-0.28175—67.1%15.2%0

As of September 28, 2026

Run the Wheel on EYES With Confidence

Find the best EYES wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial